Skip to content

PolitiKit

Lobbying by McKesson Canada: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.

← Lobbying

Client of a consultant lobbyist

McKesson Canada

Meetings this Parliament
9
With MPs
1
Since Nov 2021
17
Active registrations
0

Most recent reported meeting: Apr 21, 2026.

Registrations in effect

McKesson Canada has no active registration. Organizations must register once paid lobbying passes the legal threshold, and their registration ends when it stops.

Reported meetings

Spreadsheet
  • Reported by Frédérik Larouche · Consultant

    • Anthony Laporte · Strategic Advisor, Implementation and Delivery, Prime Minister's Office (PMO)
    Health and security policies and programs relating to the domestic distribution of products and the integrity of the supply chain.

    Official report

  • Reported by Frédérik Larouche · Consultant

    • Shalene Curtis-Micallef · Deputy Minister, Health Canada (HC)
    Health and security policies and programs relating to the domestic distribution of products and the integrity of the supply chain.

    Official report

  • Reported by Frédérik Larouche · Consultant

    • Jade Mallette · Director of Parliamentary Affairs, Health Canada (HC)
    Health and security policies and programs relating to the domestic distribution of products and the integrity of the supply chain.

    Official report

  • Reported by Frédérik Larouche · Consultant

    • Marjorie Michel · Minister, Health Canada (HC)
    • Sandenga Yeba · Director of Policy, Health Canada (HC)
    Health and security policies and programs relating to the domestic distribution of products and the integrity of the supply chain.

    Official report

  • Reported by Frédérik Larouche · Consultant

    • Sendenga Yeba · Director of Policy, Health Canada (HC)
    • Yves-Joseph Rosalbert · Director of Operations, Health Canada (HC)
    Health and security policies and programs relating to the domestic distribution of products and the integrity of the supply chain.

    Official report

  • Reported by Frédérik Larouche · Consultant

    • Sandenga Yeba · Director of Policy, Health Canada (HC)
    Health and security policies and programs relating to the domestic distribution of products and the integrity of the supply chain.

    Official report

  • Reported by Frédérik Larouche · Consultant

    • Galen Richardson · Director of Stakeholder Engagement, Privy Council Office (PCO)
    Health and security policies and programs relating to the domestic distribution of products and the integrity of the supply chain.

    Official report

  • Reported by Frédérik Larouche · Consultant

    • Yves-Joseph Rosalbert · Director of Operations, Health Canada (HC)
    Health and security policies and programs relating to the domestic distribution of products and the integrity of the supply chain.

    Official report

  • Reported by Frédérik Larouche · Consultant

    • Neerja Bhalla · Director of Stakeholder Engagment, Global Affairs Canada (GAC)
    Health and security policies and programs relating to the domestic distribution of products and the integrity of the supply chain.

    Official report

  • Reported by Frédérik Larouche · Consultant

    • Cyndi Jenkins · Chief of Staff to the Minister, Health Canada (HC)
    • Eshan Naik · Deputy Chief of Staff and Director of Policy, Health Canada (HC)
    Health and security policies and programs relating to the domestic distribution of products and the integrity of the supply chain.

    Official report

  • Reported by Frédérik Larouche · Consultant

    • Jade Malette · Director of Parliamentary Affairs and Strategic Planning, Health Canada (HC)
    Health and security policies and programs relating to the domestic distribution of products and the integrity of the supply chain.

    Official report

  • Reported by Frédérik Larouche · Consultant

    • Jade Mallette · Director of Parliamentary Affairs, Health Canada (HC)
    Drug pricing and pharmacare with regard to the pharmaceutical wholesale distribution chain.

    Official report

  • Reported by Frédérik Larouche · Consultant

    Health

    Official report

  • Reported by Frédérik Larouche · Consultant

    • Ophelia John · Senior Policy Advisor, Health Canada (HC)

    Health

    Official report

  • Reported by Frédérik Larouche · Consultant

    • Philip Proulx · Director Executive Office - Strategic Advisor Québec, Prime Minister's Office (PMO)

    Health

    Official report

  • Reported by Frédérik Larouche · Consultant

    • Sandenga Yeba · Senior Policy Advisor, Health Canada (HC)

    HealthIndustry

    Official report

  • Reported by Frédérik Larouche · Consultant

    • Kevin McHarg · Special Advisor - Ontario, Public Services and Procurement Canada (PSPC)

    HealthIndustry

    Official report

From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.